7 years ago

uMotif Secures £2.4 Million to Expand Patient-Centric Clinical Research Platform

  • uMotif, a London-based data capture company focused on patient-centric clinical research, has secured £2.4 million in funding

  • Led by Albion Capital with participation from angel investors, the funding will be used to expand the team, enhance product capabilities, and enter the Asia Pacific market

  • uMotif's cloud-based platform provides patient-facing technology for capturing real-world data in clinical research, serving clients in Europe and North America, including top pharmaceutical companies.

      • ProblemHealthcare

      "Clinical research is often slow and expensive because it relies on traditional methods of data collection, which are prone to errors and delays. This makes it difficult to develop new treatments and cures for diseases."

      Solution

      "uMotif provides a cloud-based software platform that enables patients to collect their own data using their mobile devices. This makes clinical research more efficient, accurate, and cost-effective."

      Covered on